Status:
COMPLETED
Addressing Perinatal Depression in Deprived Areas of Istanbul, Turkey
Lead Sponsor:
Perran Boran
Collaborating Sponsors:
Medical Research Council
Conditions:
Perinatal Depression
Eligibility:
FEMALE
18-49 years
Phase:
NA
Brief Summary
In Turkey, the prevalence rate of perinatal depression has been estimated between 20%-40%, reflecting the global average of 25%. Untreated perinatal depression is of concern not only because of its ef...
Detailed Description
Systematic reviews provide robust evidence that perinatal depression can be treated effectively in low to middle income countries with psychological treatments delivered by non-specialists. The interv...
Eligibility Criteria
Inclusion
- pregnant women over 18 years between 12-30 weeks' gestation have access to internet, intend to attend all 5 sessions of the antenatal classes
Exclusion
- currently receiving any form of counselling or mental health care, who report suicidal ideation women who have a miscarriage, stillbirth or preterm birth will also be excluded from the follow-up assessment
Key Trial Info
Start Date :
April 5 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 11 2021
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT04819711
Start Date
April 5 2021
End Date
November 11 2021
Last Update
August 26 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Marmara University School of Medicine
Istanbul, Turkey (Türkiye)
2
University of Liverpool
Manchester, United Kingdom